跳至主要内容
临床试验/EUCTR2016-002162-30-CZ
EUCTR2016-002162-30-CZ进行中(未招募)1 期

Prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of 6% Hydroxyethyl (HES) starch solution versus an electrolyte solution in patients undergoing elective abdominal surgery - PHOENICS

Fresenius Kabi Deutschland GmbH0 个研究点目标入组 2,346 人开始时间: 2016年10月6日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
2,346

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Male or female adult patients > 40 and =85 years of age
  • Women of childbearing potential must test negative on standard pregnancy test (urine or serum)
  • Patients undergoing elective abdominal surgery with an expected blood loss of = 500 ml
  • ASA Physical Status II-III
  • Signed written consent form
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 1500
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 780

排除标准

  • Hypersensitivity to the active substances or to any of the other excipients of the investigational products
  • Body weight = 140 kg
  • Renal impairment (AKIN stage = 1 or chronic) or acute and/or chronic renal replacement therapy
  • Intracranial or cerebral haemorrhage
  • Critically ill patients (typically admitted to the intensive care unit)
  • Dehydration
  • Hyperhydration
  • Pulmonary oedema
  • Congestive heart failure
  • Severe hypernatraemia
  • Severe hyperchloraemia
  • Hyperkalaemia
  • Metabolic alkalosis
  • Severely impaired hepatic function
  • Severe coagulopathy
  • Organ transplant patients
  • Simultaneous participation in another interventional trial (drugs or medical device)

研究者

相似试验

已完成
4 期
Prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution in patients undergoing elective abdominal surgery'Hypovolaemia' + 'Decreased blood volume'10014412
NL-OMON53031PRA Belgium BV350
进行中(未招募)
1 期
Prospective, randomized, controlled, double-blind, multi-centre,multinational study on the safety and efficacy of 6% Hydroxyethyl starch(HES) solution versus an electrolyte solution in patients undergoingelective abdominal surgery-PHOENICS
EUCTR2016-002162-30-ROFresenius Kabi Deutschland GmbH2,280
进行中(未招募)
1 期
Controlled, international study conducted in several centres on the safety and therapeutic effect of a Hydroxylethyl-starch (HES) solution versus an electrolyte solution in patients undergoing elective abdominal surgeryHypovolaemia due to acute blood loss in elective abdominal surgeryMedDRA version: 19.1Level: PTClassification code 10021137Term: HypovolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2016-002162-30-ESB. Braun Melsungen AG2,280
进行中(未招募)
1 期
Controlled, international study conducted in several centres on the safety and therapeutic effect of a Hydroxylethyl-starch (HES) solution versus an electrolyte solution in patients undergoing elective abdominal surgeryHypovolaemia due to acute blood loss in elective abdominal surgeryMedDRA version: 20.0Level: PTClassification code 10021137Term: HypovolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2016-002162-30-NLFresenius Kabi Deutschland GmbH2,280
进行中(未招募)
不适用
Trial with two lipid emulsions already approved for artificial nutrition to evaluate possible differences in the efficacy and safety of a fish oil containing lipid emulsion versus a standard soybean oil-based lipid emulsion in patients with Acute Lung InjuryAcute Lung Injury as a result of proven pneumonia (x-ray) or witnessed aspirationMedDRA version: 16.1Level: PTClassification code 10069351Term: Acute lung injurySystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2011-003397-82-DEB. Braun Melsungen AG